Verified Document

Granting Patents On Genes I Thesis

Related Topics:

I wonder if Europe is experiencing similar issues with the motivation system for its examiners. They could be pushed into demanding higher quality. However, compared to the drops in the U.S., the drops in Europe are not as staggering. Or the quality of patent applications is genuinely decreasing. The bigger issue as I see it is trying to determine if the decrease in patent rates is directly indicative of an environment where researchers feel stifled. If that is the case, at what point do the demands for high quality applications have a negative net impact on society rather than a positive one?

Response to Article 2: This is scary. The drug and biotech industries have a complex enough relationship with the legal system already, without adding fifty-one other jurisdictions into the mix. That the Supreme Court justices did not consider the vagueness of the "not strong enough" concept is also alarming. If this term is not defined,...

It's in Congress' hands now, to rewrite the laws. The system was not intended to work in this fashion. Moreover, how does this impact the marketing side of the equation? The decision to enter states will be taken on a case-by-case basis depending on their profitability. Vermont, incidentally, would be one of the states most hurt by this decision. States don't even have labeling approval processes, yet now they can allow juries to make up their own version of an adequate label, levying instant punishment of millions of dollars on the unknowing transgressor. For the industry, the prospect of fifty label approval processes in addition to FDA approval is a nightmare. And people wonder why treatment costs are going through the roof?

Cite this Document:
Copy Bibliography Citation

Related Documents

Patent System a Patent Is
Words: 694 Length: 2 Document Type: Essay

Thus, according to Heller and Eisenberg, useful innovations that build on earlier patented inventions can be inhibited by the high transaction costs from negotiating with the earlier patentees. There are several compelling arguments that patents aren't really that economically efficient for organizations. For instance, Bessen and Meurer (2008) point out the complexity of the patent system; stating that a prospective technology investor would need to check a very large number

Research Grant National Institutes of Health Research
Words: 1172 Length: 4 Document Type: Research Paper

Research Grant National Institutes of Health Research Grant This essay examines the application process for the National Institutes of Health (NIH) research grant through the National Human Genome Research Institute (NHGRI), Funding Opportunity Title Genomic Resource Grants for Community Resource Projects (U41), Funding Opportunity Announcement Number PAR-11-095. The NHGRI was established originally as the National Center for Human Genome research in 1989 and led the NIH's contribution to the Human Genome Project. This

Patenting Genes: Should It Be
Words: 1188 Length: 4 Document Type: Term Paper

They are therefore no different to any other derivative that comes from plant or mineral and has been altered to provide some useful medicinal diagnosis. Laypeople react with revulsion since they are unaware of the scientific steps that have gone into the procedure and resulted in a totally modified entity. Were they aware of this, ethical concerns may be obliterated. Issue 20 -- Should the world continue to rely on

Decline of the American Diet
Words: 5127 Length: 15 Document Type: Term Paper

The meat comes from a local independent packing company that doesn't buy beef that has been injected with growth hormones; the buns are from a bakery in Pueblo, Colorado; and two hundred pounds of potatoes are "peeled every morning in the kitchen and then sliced with an old crank-operated contraption." The cooks make $10 an hour, and all other employees earn $8.00 an hour. When asked why the Conway

Human Stem Cell Medical -
Words: 4660 Length: 17 Document Type: Term Paper

This bill was sent to the U.S. Senate and set for vote mirroring a bill previously passed by the House during the Summer of 2003 which failed to pass the Senate because of vehement disagreement that was even "within the parties over the prohibition of therapeutic cloning.(National Legislation Concerning Human and Reproductive Cloning, 2004; paraphrased) As of the date of the report on legislation eight U.S. states had passed

Pharma Joan Busfield N.D. Explores
Words: 1293 Length: 4 Document Type: Essay

Demand is dependent on the frequency of a condition in the population. This number, for most conditions, is generally known. Thus, the equilibrium point can be determined that would deliver the cost recovery and markup pharma companies seek, without allowing costs to escalate to gouging levels. The problem is that once the monopoly has been granted there are no serious cost controls beyond market controls. There are two problems with

Sign Up for Unlimited Study Help

Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.

Get Started Now